Partners AMR Insights
For its global activities AMR Insights is dependent on its highly valued partners.
Our current partners:
LifeArc is a self-funded, charitable medical research organisation committed to spending £1.3 billion by 2030 in areas of high unmet medical need. Their teams are experts in drug and diagnostics discovery, technology transfer, and intellectual property and their work focuses on translational science – bridging the gap between academic research and clinical development. They provide funding, research and expert knowledge, all with a clear and unwavering commitment to having a positive impact on patient lives. They have been doing this for more than 25 years and their work has contributed to five licensed medicines, including cancer drug pembrolizumab (Keytruda®), and a diagnostic for antibiotic resistance.
IFPMA represents the research-based pharmaceutical companies and associations across the globe. The research-based pharmaceutical industry’s 2 million employees research, develop and provide medicines and vaccines that improve the life of patients worldwide. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community find solutions that improve global health.
Addressing the human health impacts of AMR will require building a strong and motivated coalition of like-minded health officials, clinicians, laboratorians, policymakers, patients and leaders.
BBC is a joint initiative of Department of Biotechnology, Government of India and Department of Electronics, IT, BT and S&T, Government of Karnataka. BBC is a State-of-the-art translational research and entrepreneurship centre catering to all the needs of start-ups in life science.